Navigation Links
Results of Linjeta™ Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting
Date:9/21/2010

DANBURY, Conn., Sept. 21 /PRNewswire/ -- In a platform presentation at the 46th annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, investigators for Biodel Inc. (Nasdaq: BIOD) today presented the results of a clinical study evaluating a new pH-neutral formulation of Linjeta™ (VIAject®).   Dr. Tim Heise (Profil Institute for Metabolic Research, Neuss, Germany) and colleagues reported that the new pH-neutral, 100 IU/ml formulation of Linjeta™ was bioequivalent to the previously studied pH-4, 25 IU/ml formulation of Linjeta™, and had faster absorption and onset of action than insulin lispro.  These findings were also presented by Dr. Heise in June at the 70th scientific sessions of the American Diabetes Association in Orlando, Florida.

Linjeta™ is Biodel's more-ultra-rapid-acting insulin formulation that is currently under review by the U.S. Food and Drug Administration.  The purpose of this study was to demonstrate the bioequivalence of the two formulations of Linjeta™, compare the pharmacokinetic and pharmacodynamic characteristics of pH-neutral, 100 IU/ml Linjeta™ and insulin lispro in 43 patients with Type 1 diabetes.  The trial was conducted as a randomized, double-blind crossover study.  There were no serious adverse events or discontinuations because of treatment-emergent adverse events; headache was the most frequent adverse event reported (8 patients).  Additional studies are planned to evaluate the impact of Linjeta™ on glucose control.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes. Biodel's product candidates are developed using VIAdel™ technology, which reformulates existing FDA-approved peptide drugs.  Biodel's new d
'/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
2. Dynatronics to Release Fourth Quarter and Year-End Results Wednesday, September 22, 2010; Conference Call Set for 1:00 p.m. ET
3. LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results
4. Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for Treatment of Major Depressive Disorder
5. Corgenix to Host Conference Call to Discuss Fiscal 2010 Results
6. Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
7. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
8. Renhuang Schedules Conference Call to Discuss FY 2010 Third Quarter Results
9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
10. Streamline Health® Solutions Reports Q2 Results
11. ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmins Potential to Transform the Treatment of Retinal Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. ... in China , today announced that it ... ended March 31, 2013, before market on Tuesday, May 28, ... May 28, 2013, at 8:00 a.m. EDT (May 28, 2013 ... financial results and provide an update on recent corporate developments. ...
(Date:5/16/2013)... , May 16, 2013  PTC Therapeutics, Inc., ... on Form S-1 with the U.S. Securities and Exchange ... of its common stock. The number of shares to ... have not been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ... are acting as joint book-running managers for the offering. ...
(Date:5/16/2013)... WALTHAM, Mass. , May 16, 2013  Alere Inc. ... individuals to take charge of their health at home through ... a cash dividend of $3.00 per share on its Series ... payable on July 15, 2013 to holders of record of ... 1, 2013.  Such payment will cover the amount ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Magnetically Guided Nanoparticles May Deliver Treatments to Human,Organs -, ... and tiny iron-bearing particles to drive healthy cells to,targeted ... may lead to,a new method of delivering cells and ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080107/DC10966 ), The study team, ...
... 7 Fovea Pharmaceuticals SA, which, last,December ... financing, today announced that,its product, Recombinant human ... as Orphan Medicinal Product from the,European Commission, ... for the Evaluation of Medicinal Products (EMEA) ...
Cached Medicine Technology:Researchers Use Magnetism to Target Cells to Animal Arteries 2Researchers Use Magnetism to Target Cells to Animal Arteries 3Researchers Use Magnetism to Target Cells to Animal Arteries 4Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 2Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 3
(Date:5/19/2013)... According to a May 14th, 2013 Harper’s Bazaar ... about the appearance of certain areas of the body. ... fail to tone and tighten these areas. The report details ... get the firmest body possible (article: goo.gl/tPiha). , ... Simon Ourian, Medical Director of Epione Beverly Hills. “I don’t ...
(Date:5/19/2013)... York (PRWEB) May 19, 2013 ... a federal litigation now underway in U.S. District Court, ... Management Order dated May 3rd, the Court has modified ... Pool to eight cases rather than four. The next ... for Thursday, May 23rd. (In re: Actos Product Liability ...
(Date:5/19/2013)... 19, 2013 6Webs.com is the leader ... Homeowners who are considering an alarm system can do ... nation's leading security system providers online at 6Webs.com. Just ... best DIY home security system companies, 6Webs.com currently ... dozens of home security companies before ranking the home ...
(Date:5/19/2013)... Americans live closer to their dogs than ... Medical Association (AVMA) U.S. Pet Ownership and Demographics Sourcebook, ... dog a member of the family, up from the ... years earlier. , According to the American Pet Products ... dedicated to pets has increased every year without interruption, ...
(Date:5/19/2013)... Los Angeles (PRWEB) May 19, 2013 Yeast ... infections can appear in sensitive areas of the human body. ... by Yeastrol. This new formula provides a unique method of ... This new spray solution is now provided to men and ... Yeast is naturally absorbed in the body through food and ...
Breaking Medicine News(10 mins):Health News:Body Firming – The Hottest Treatments Available 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2
... help the human brain to enhance memories like the ability ... that previous studies had established the benefits of sleep for ... sequences on a keyboard. It was explained that the new ... recalling the facts for a test, where in the brain's ...
... assess obesity rather than body mass index (BMI), the huge ... example, is cut in half, and white men are found ... men. ,While the medical literature has long showed ... of fatness than BMI, most social science researchers still use ...
... of the 10-month-old conjoined twins, who were separated last week ... place on Thursday, was hailed as a "miracle" by the ... Hu Jingxuan, was unable to tolerate the stress. ... the twins, Chen Jingni, was in a stable condition, while ...
... fast lane, business competition, deadlines and staff constraints stresses ... family, books and holidays //for relief, says a new ... leaders coping with work pressure suffers more from mental ... of Commerce and Industry of India) Business Barometer (ABB) ...
... has caused Australian businesses stockpile anti-viral drugs and face masks. ... have regular meetings regularly Public companies such as Bluescope Steel ... planning project manager. ,Expanded computer networks to enable ... outbreak have been included in the preparations against bird flu. ...
... warned people against consuming uncooked oysters imported from Korea. ... to be cooked before consuming. The warning is mainly ... which causes a gastrointestinal illness. ,In ... 1kg bags and labeled according to the current import ...
Cached Medicine News:Health News:Sleep Essential For A Strong Memory 2Health News:Family, Books Best Stress-busters for Indian CEOs 2Health News:Australian Businesses Prepare for Outbreak of Bird Flu 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: